Parotid Neoplasms: Clinical Trials

3 trials for Parotid Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 completed. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 2, Completed 1
Phase 11Completed 1

Follow Parotid Neoplasms: new trials by email Literature Review of Parotid Neoplasms trials Research Report on Parotid Neoplasms

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
Best Practice, Medical Device Usage and Evaluation - Head and Neck Carcinoma, Malignant Parotid Gland Neoplasm
Phase 2Active not recruitingM.D. Anderson Cancer Center882021-05-262026-10-06
Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery
Bevonescein - Parotid Neoplasm, Thyroid Neoplasms
Phase 1 / Phase 2CompletedAlume Biosciences, Inc.272020-06-182025-05-08
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
pembrolizumab - Advanced Cancer, Anal Carcinoma
Phase 2Active not recruitingMerck Sharp & Dohme LLC16092015-12-182025-09-22

Narrower conditions

Thyroid Neoplasms (2)  ·  Anus Neoplasms (1)  ·  Bile Duct Neoplasms (1)  ·  Biliary Tract Neoplasms (1)  ·  Carcinoid Tumor (1)  ·  Cholangiocarcinoma (1)  ·  Colorectal Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Maxillary Sinus Neoplasms (1)  ·  Mesothelioma (1)  ·  Microsatellite Instability (1)  ·  Mouth Neoplasms (1)  ·  Neuroendocrine Tumors (1)

Broader conditions

Mouth Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Parotid Diseases (3)  ·  Salivary Gland Diseases (3)  ·  Stomatognathic Diseases (3)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Head and Neck Neoplasms (2)  ·  Mouth Neoplasms (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Neoplasms (2)  ·  Salivary Gland Neoplasms (2)  ·  Thyroid Diseases (2)  ·  Adenocarcinoma (1)

Interventions

Practice Guidelines as Topic (1)  ·  Standard of Care (1)  ·  pembrolizumab (1)

Sponsors

Alume Biosciences, Inc. (1)  ·  M.D. Anderson Cancer Center (1)  ·  Merck Sharp & Dohme LLC (1)

Countries

United States (2)

Top investigators

Anna Lee (1)

Results publications

PMID 30943124, PMID 31682550, PMID 31980466, PMID 32359091, PMID 32919526, PMID 33836153, PMID 34990208, PMID 35114169, PMID 35361487, PMID 35588692, PMID 35680043, PMID 35777186, PMID 35835611, PMID 36748723, PMID 39979665, PMID 40121391, PMID 40595556, PMID 41920388

NIH funding

2015 (1)